US › Healthcare

Vivani Medical Inc. (VANI)

US · Healthcare · Biotechnology

$1.12-2.61%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-6.4M

EPS

$-0.07

EPS estimate

$-0.08

EPS came in at -0.07 against a street estimate of -0.08 — a beat of 12.5%.

Key statistics

Market cap

$104.6M

Forward P/E

0.0

P/B

5.85

Book value

$0.21

EPS (TTM)

$-0.36

52-week high

$1.92

52-week low

$0.92

50-day MA

$1.32

200-day MA

$1.27

Beta

3.30

Analyst view

Analysts rate Vivani Medical Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $3.83.

Shareholding

Insiders

55.39%

Institutions

5.87%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.96%
Tanager Wealth Management LLP	0.67%
Geode Capital Management, LLC	0.65%
Tudor Investment Corp Et AL	0.46%
Commonwealth Equity Services, LLC	0.37%
Vanguard Fiduciary Trust Co	0.36%
BlackRock Inc	0.33%
Monetary Management Group Inc	0.21%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Vivani Medical Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.